These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7611194)

  • 21. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
    Xu QW; Scott RB; Tan DT; Shaffer EA
    Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss.
    Gebhard RL; Prigge WF; Ansel HJ; Schlasner L; Ketover SR; Sande D; Holtmeier K; Peterson FJ
    Hepatology; 1996 Sep; 24(3):544-8. PubMed ID: 8781321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue SMS201-995 in patients of active acromegaly].
    Zhu XF; Shi YF; Zhang JX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):405-8, 455. PubMed ID: 1752152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential site of disordered gallbladder contractility during the early stage of cholesterol gallstone formation.
    Mansour A; Dawoud I; Gad-El-Hak N
    Hepatogastroenterology; 1998; 45(23):1404-9. PubMed ID: 9840074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Debut of a somatostatin analog: octreotide in review.
    Zindel LR
    Conn Med; 1989 Dec; 53(12):741-4. PubMed ID: 2558839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of biliary proteins in pathogenesis of cholesterol gallstones].
    Secknus R; Holzbach RT
    Z Gastroenterol; 1997 Jan; 35(1):41-6. PubMed ID: 9123957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of gallbladder motility to viscosity and composition of gallbladder bile in patients with cholesterol gallstones.
    Gründel D; Jüngst C; Straub G; Althaus R; Schneider B; Spelsberg FW; Hüttl TP; del Pozo R; Jüngst D; Neubrand M
    Digestion; 2009; 79(4):229-34. PubMed ID: 19390195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term treatment with octreotide of patients with acromegaly].
    Weeke J; Orskov H; Christensen SE; Kaal A; Skjaerbaek C; Illum P; Jørgensen J; Lund E; Haubek A; Poulsen JH
    Ugeskr Laeger; 1993 Aug; 155(34):2592-8. PubMed ID: 8212364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly. A prospective study.
    Erlinger S; Chanson P; Dumont M; Ponsot P; Warnet A; Harris AG
    Dig Dis Sci; 1994 Nov; 39(11):2384-8. PubMed ID: 7956607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory studies and special tests for assessing gallbladder and bile duct function].
    Méndez-Sánchez N; Bosques Padilla F; Uribe Esquivel M
    Rev Gastroenterol Mex; 1993; 58(2):136-44. PubMed ID: 7747024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment].
    Buscail LE; Puel-Bousquet C; Harris AG; Tauber JP; Escourrou JR; Delvaux MM; Vaysse NM; Bayard F; Ribet A
    Gastroenterol Clin Biol; 1991; 15(11):800-4. PubMed ID: 1769469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short-term octreotide therapy and total parenteral nutrition on the development of biliary sludge and lithiasis.
    Baudet S; Medina C; Vilaseca J; Guarner L; Sureda D; Andreu J; Malagelada JR
    Hepatogastroenterology; 2002; 49(45):609-12. PubMed ID: 12063951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bile salts on in vitro gallbladder motility: preliminary study.
    Stolk MF; Van de Heijning BJ; Van Erpecum KJ; Verheem A; Akkermans LM; Van Berge-Henegouwen GP
    Ital J Gastroenterol; 1996; 28(2):105-10. PubMed ID: 8782005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Octreotide promotes gallbladder absorption in prairie dogs: a potential cause of gallstones.
    Moser AJ; Abedin MZ; Giurgiu DI; Roslyn JJ
    Gastroenterology; 1995 May; 108(5):1547-55. PubMed ID: 7729647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide stimulates Ca++ secretion by the gallbladder: a risk factor for gallstones.
    Moser AJ; Giurgiu DI; Morgenstern KE; Abedin ZR; Roslyn JJ; Abedin MZ
    Surgery; 1999 May; 125(5):509-13. PubMed ID: 10330939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An experimental study on preventing gallstone formation by exogenous cholecystokinin].
    Qian ZP
    Zhonghua Wai Ke Za Zhi; 1989 Mar; 27(3):135-6, 187. PubMed ID: 2776550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs affecting biliary lipid secretion and gallbladder motility: their potential role in gallstone treatment and prevention.
    vanBerge-Henegouwen GP; Venneman NG; van Erpecum KJ; Portincasa P
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):185-91. PubMed ID: 16089351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oleic acid-induced cholelithiasis in rabbits. Changes in bile composition and gallbladder morphology.
    Lee SP; Tasman-Jones C; Carlisle V
    Am J Pathol; 1986 Jul; 124(1):18-24. PubMed ID: 3728645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones.
    Hussaini SH; Murphy GM; Kennedy C; Besser GM; Wass JA; Dowling RH
    Gastroenterology; 1994 Nov; 107(5):1503-13. PubMed ID: 7926514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.